New Delhi: Drug firm Dr Reddy`s Laboratories today said it has launched generic Zoledronic Acid injection in the American market following approval by the US health regulator.The company has launched Zoledronic Acid injection in the strength of 4mg/5mL following the approval of its abbreviated new drug application (ANDA) by the United States Food & Drug Administration (USFDA), the company said in a statement.The product is a generic version of Novartis Oncology`s Zometa (zoledronic acid) injection in the same strength.
BRICS Summit, an opportunity to discuss vital issues: PM Modi
Controversy over Ved Pratap`s meeting with Hafiz Saeed
Sawan rituals begin; devotees swarm Shiv temples
UPSC aspirants protest outside Rajnath Singh`s residence